 |
|
Facial Nerve in Recurrent Benign Pleomorphic Adenoma
John Conley, MD;
Albert A. Clairmont, MD
Arch Otolaryngol. 1979;105(5):247-251.
Abstract
• Improvements in the treatment of benign and malignant tumors in the parotid gland have substantially reduced the incidence of recurrence. This has come about primarily by the abandonment of the enucleation techniques and the development of the lateral lobectomy operation. The recurrence rate for benign mixed tumor in the parotid gland is variously reported in the ranges of 0.5% to 10%. Because the benign mixed tumor comprises approximately 65% of the tumors in this gland, this complication assumes an important and specific role. A review of this problem establishes the principles of management, extending from simple reexcision through total parotidectomy with preservation of the facial nerve, and radical parotidectomy with resection of the facial nerve and immediate nerve grafting.
(Arch Otolaryngol 105:247-251, 1979)
Author Affiliations
From the Department of Otolaryngology, Columbia-Presbyterian Medical Center, the Head and Neck Service, St Vincent's Hospital, and the Pack Medical Foundation, New York. Dr Clairmont is now in private practice in Atlanta.
Footnotes
Accepted for publication Feb 4, 1978.
Reprint requests to Department of Otolaryngology, Columbia-Presbyterian Medical Center, New York, NY 10032 (Dr Conley).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Sclerosing Polycystic Sialadenopathy: A Rare Cause of Recurrent Tumor of the Parotid Gland
Mackle et al.
Arch Otolaryngol Head Neck Surg 2004;130:357-360.
ABSTRACT
| FULL TEXT
Surgical Treatment of Recurrent Pleomorphic Adenoma of the Parotid Gland
Niparko et al.
Arch Otolaryngol Head Neck Surg 1986;112:1180-1184.
ABSTRACT
Recurrent Pleomorphic Adenomas of the Parotid Gland
Maran et al.
Arch Otolaryngol Head Neck Surg 1984;110:167-171.
ABSTRACT
|
